MedPath

Etude clinique prospective randomisée en double aveugle de phase 4 comparant la durée d'analgésie postopératoire du fentanyl et du sufentanil administrés comme adjuvant en rachianesthésie dans le cadre de césariennes électives. - SUFRACES

Phase 1
Conditions
Pregnant patients with a planned caesarian.
MedDRA version: 12.1Level: LLTClassification code 10067385Term: Spinal analgesia
Registration Number
EUCTR2010-023528-25-BE
Lead Sponsor
CHU Brugmann
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
180
Inclusion Criteria

- 18 years or older
- planned caesarian
- signed informed consent form

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- loco-regional anesthesia not indicated or refused
- sensitivity to one of the used products
- participation to another clinical trial

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To delay the first use of morphine after intrathecal anesthesia.;Secondary Objective: - To reduce the quantity of morphine used 24h and 48h after the intrathecal anesthesia.<br><br>- Safety assessment through the frequence of nausea, vomiting and pruritus 24h and 48h after the intrathecal anesthesia;Primary end point(s): Time until the first use of morphine from the intrathecal anesthesia<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath